Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Change in Inventory (2020 - 2025)

Biofrontera has reported Change in Inventory over the past 6 years, most recently at $872000.0 for Q4 2025.

  • Quarterly results put Change in Inventory at $872000.0 for Q4 2025, up 493.2% from a year ago — trailing twelve months through Dec 2025 was -$1.4 million (up 65.86% YoY), and the annual figure for FY2025 was -$1.4 million, up 65.86%.
  • Change in Inventory for Q4 2025 was $872000.0 at Biofrontera, up from $301000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for BFRIW hit a ceiling of $8.1 million in Q2 2023 and a floor of -$5.1 million in Q4 2023.
  • Median Change in Inventory over the past 5 years was $14000.0 (2024), compared with a mean of -$85500.0.
  • Biggest five-year swings in Change in Inventory: plummeted 702.2% in 2024 and later surged 493.2% in 2025.
  • Biofrontera's Change in Inventory stood at -$979000.0 in 2021, then tumbled by 402.35% to -$4.9 million in 2022, then dropped by 4.72% to -$5.1 million in 2023, then soared by 102.85% to $147000.0 in 2024, then surged by 493.2% to $872000.0 in 2025.
  • The last three reported values for Change in Inventory were $872000.0 (Q4 2025), $301000.0 (Q3 2025), and -$2.5 million (Q2 2025) per Business Quant data.